Herrera-Gayol and Jothy [42] showed that CD44 variants (especially CD44v6) could regulate the binding of breast cancer cells to extracellular HA, and these binding interactions could mediate tumor cell metastasis. This evidence concerns the gene CD44 and neoplasm.